Association of OPRD1 polymorphisms with heroin dependence in a large case-control series

Addiction Biology

Volumn 19, Issue 1, 2014, Pages 111-121

  Nelson, Elliot C ^a   Lynskey, Michael T ^a   Heath, Andrew C ^a   Wray, Naomi ^b   Agrawal, Arpana ^a   Shand, Fiona L ^c   Henders, Anjali K ^b   Wallace, Leanne ^b   Todorov, Alexandre A ^a   Schrage, Andrew J ^a   Madden, Pamela A F ^a   Degenhardt, Louisa ^c,d   Martin, Nicholas G ^b   Montgomery, Grant W ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Association study; case control; heroin dependence; OPRD1; OPRK1; OPRM1

Indexed keywords

BUPRENORPHINE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; METHADONE; MU OPIATE RECEPTOR;

ADULT; ALCOHOLISM; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DEPENDENCE; DSM-IV; ENVIRONMENTAL FACTOR; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; HAPLOTYPE; HAPLOTYPE MAP; HEREDITY; HEROIN DEPENDENCE; HUMAN; HUMAN EXPERIMENT; MAINTENANCE THERAPY; MALE; NEIGHBORHOOD; OPIATE ADDICTION; PHENOTYPE; PRIORITY JOURNAL; QUALITY CONTROL; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; TWINS;

ASSOCIATION STUDY; CASE-CONTROL; HEROIN DEPENDENCE; OPRD1; OPRK1; OPRM1;

ADULT; CASE-CONTROL STUDIES; CONTROL GROUPS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HAPMAP PROJECT; HEROIN DEPENDENCE; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW SOUTH WALES; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; TWINS;

EID: 84890795563     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2012.00445.x     Document Type: Article

References (51)

1. Allen PB, Greenfield AT, Svenningsson P, Haspeslagh DC, Greengard P, (2004) Phactrs 1-4: a family of protein phosphatase 1 and actin regulatory proteins. Proc Natl Acad Sci U S A 101: 7187-7192.
2. Andrews G, Peters L, (1998) The psychometric properties of the Composite International Diagnostic Interview. Soc Psychiatry Psychiatr Epidemiol 33: 80-88.
3. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
4. Bart G, Heilig M, LaForge KS, Pollak L, Leal SM, Ott J, Kreek MJ, (2004) Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry 9: 547-549.
5. Berger AC, Whistler JL, (2010) How to design an opioid drug that causes reduced tolerance and dependence. Ann Neurol 67: 559-569.
6. Bhushan RG, Sharma SK, Xie Z, Daniels DJ, Portoghese PS, (2004) A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers. J Med Chem 47: 2969-2972.
7. Bie B, Zhang Z, Cai YQ, Zhu W, Zhang Y, Dai J, Lowenstein CJ, Weinman EJ, Pan ZZ, (2010) Nerve growth factor-regulated emergence of functional delta-opioid receptors. J Neurosci 30: 5617-5628.
8. Billa SK, Xia Y, Morõn JA, (2010) Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse. Eur J Neurosci 32: 625-631.
9. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, Tischfield JA, Kreek MJ, Yu L, (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A 95: 9608-9613.
10. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JI Jr, Reich T, Schmidt I, Schuckit MA, (1994) A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 55: 149-158.
11. Christie MJ, (2008) Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol 154: 384-396.
12. Coller JK, Beardsley J, Bignold J, Li Y, Merg F, Sullivan T, Cox TC, Somogyi AA, (2009) Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: a meta-analysis. Pharmgenomics Pers Med 2: 9-19.
13. Daniels DJ, Lenard NR, Etienne CL, Law PY, Roerig SC, Portoghese PS, (2005) Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc Natl Acad Sci U S A 102: 19208-19213.
14. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D, (2005) Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223.
15. Degenhardt L, Hall W, Warner-Smith M, Lynskey M, (2004) Illicit drug use. In:, Ezzati M, Lopez AD, Rodgers A, Murray CJL, eds. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors, Vol. 1, 1109-1175. Geneva, Switzerland: World Health Organization (WHO).
16. Ferré S, Franco R, (2010) Oligomerization of G-protein-coupled receptors: a reality. Curr Opin Pharmacol 10: 1-5.
17. Franke P, Nothen MM, Wang T, Neidt H, Knapp M, Lichtermann D, Weiffenbach O, Mayer P, Holt B, Propping P, Maier W, (1999) Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence. Am J Med Genet 88: 462-464.
18. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A, Diekhans M, Dreszer TR, Giardine BM, Harte RA, Hillman-Jackson J, Hsu F, Kirkup V, Kuhn RM, Learned K, Li CH, Meyer LR, Pohl A, Raney BJ, Rosenbloom KR, Smith KE, Haussler D, Kent WJ, (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res 39: D876-D882.
19. Glatt SJ, Bousman C, Wang RS, Murthy KK, Rana BK, Lasky-Su JA, Zhu SC, Zhang R, Li J, Zhang B, Li J, Lyons MJ, Faraone SV, Tsuang MT, (2007) Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. Drug Alcohol Depend 90: 159-165.
20. Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, Lim M, Maillet E, Junek M, Cahill CM, Harkany T, Devi LA, (2010) Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal 3: ra54.
21. Hansell NK, Agrawal A, Whitfield JB, Morley KI, Gordon SD, Lind PA, Pergadia ML, Montgomery GW, Madden PA, Todd RD, Heath AC, Martin NG, (2009) Can we identify genes for alcohol consumption in samples ascertained for heterogeneous purposes? Alcohol Clin Exp Res 33: 729-739.
22. He SQ, Zhang ZN, Guan JS, Liu HR, Zhao B, Wang HB, Li Q, Yang H, Luo J, Li ZY, Wang Q, Lu YJ, Bao L, Zhang X, (2011) Facilitation of μ-opioid receptor activity by preventing d-opioid receptor-mediated codegradation. Neuron 69: 120-131.
23. Hodgkinson CA, Yuan Q, Xu K, Shen PH, Heinz E, Lobos EA, Binder EB, Cubells J, Ehlers CL, Gelernter J, Mann J, Riley B, Roy A, Tabakoff B, Todd RD, Zhou Z, Goldman D, (2008) Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43: 505-515.
24. Le Merrer J, Becker JA, Befort K, Kieffer BL, (2009) Reward processing by the opioid system in the brain. Physiol Rev 89: 1379-1412.
25. Levran O, Londono D, O'Hara K, Nielsen DA, Peles E, Rotrosen J, Casadonte P, Linzy S, Randesi M, Ott J, Adelson M, Kreek MJ, (2008) Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav 7: 720-729.
26. Li J, Ji L, (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95: 221-227.
27. Lomelin D, Jorgenson E, Risch N, (2010) Human genetic variation recognizes functional elements in noncoding sequence (Letter). Genome Res 20: 311-319.
28. Mahajan SD, Aalinkeel R, Reynolds JL, Nair BB, Sykes DE, Hu Z, Bonoiu A, Ding H, Prasad PN, Schwartz SA, (2009) Therapeutic targeting of 'DARPP-32': a key signaling molecule in the dopaminergic pathway for the treatment of opiate addiction. Int Rev Neurobiol 88: 199-222.
29. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, Zhang H, O'Malley SS, Rounsaville BJ, (1998) Familial transmission of substance use disorders. Arch Gen Psychiatry 55: 973-979.
30. Narita M, Matsushima Y, Niikura K, Narita M, Takagi S, Nakahara K, Kurahashi K, Abe M, Saeki M, Asato M, Imai S, Ikeda K, Kuzumaki N, Suzuki T, (2010) Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference. Addict Biol 15: 434-447.
31. Nyholt DR, (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74: 765-769.
32. Olmstead MC, Ouagazzal AM, Kieffer BL, (2009) Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. PLoS ONE 4: e4410.
33. Patterson N, Price AL, Reich D, (2006) Population structure and eigenanalysis. PLoS Genet 2: e190.
34. Peters K, Wiltshire S, Henders AK, Dragovic M, Badcock JC, Chandler D, Howell S, Ellis C, Bouwer S, Montgomery GW, Palmer LJ, Kalaydjieva L, Jablensky A, (2008) Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes. Am J Med Genet B Neuropsychiatr Genet 147B: 1159-1166.
35. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC, (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
36. Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy J, Logan J, Zubieta J-K, Lerman C, (2011) Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci U S A 108: 9268-9273.
37. Shand FL, Degenhardt L, Nelson EC, Mattick RP, (2010) Predictors of social anxiety in an opioid dependent sample and a control sample. J Anxiety Disord 24: 49-54.
38. Shippenberg TS, Chefer VI, Thompson AC, (2009) Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biol Psychiatry 65: 169-174.
39. Svenningsson P, Nairn AC, Greengard P, (2005) DARPP-32 mediates the actions of multiple drugs of abuse. AAPS J 7: E353-E360.
40. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, True W, Lin N, Toomey R, Eaves L, (1998) Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55: 967-972.
41. Tuusa JT, Leskelä TT, Petäjä-Repo UE, (2010) Human delta opioid receptor biogenesis is regulated via interactions with SERCA2b and calnexin. FEBS J 277: 2815-2829.
42. van Rijn RM, Whistler JL, (2009) The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake. Biol Psychiatry 66: 777-784.
43. von Zastrow M, (2010) Regulation of opioid receptors by endocytic membrane traffic: mechanisms and translational implications. Drug Alcohol Depend 108: 166-171.
44. Wand GS, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S, Ali A, (2002) The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26: 106-114.
45. Yekkirala AS, Kalyuzhny AE, Portoghese PS, (2010) Standard opioid agonists activate heteromeric opioid receptors: evidence for morphine and [d-Ala2-MePhe4-Glyol5]enkephalin as selective μ-d agonists. ACS Chem Neurosci 1: 146-154.
46. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, Castagne R, Maouche S, Germain M, Lackner K, Rossmann H, Eleftheriadis M, Sinning CR, Schnabel RB, Lubos E, Mennerich D, Rust W, Perret C, Proust C, Nicaud V, Loscalzo J, Hübner N, Tregouet D, Münzel T, Ziegler A, Tiret L, Blankenberg S, Cambien F, (2010) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS ONE 5: e10693.
47. Zhang D, Shao C, Shao M, Yan P, Wang Y, Liu Y, Liu W, Lin T, Xie Y, Zhao Y, Lu D, Li Y, Jin L, (2007) Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. Biol Psychiatry 61: 1244-1251.
48. Zhang H, Kranzler HR, Yang BZ, Luo X, Gelernter J, (2008) The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 13: 531-543.
49. Zhang H, Luo X, Kranzler HR, Lappalainen J, Yang BZ, Krupitsky E, Zvartau E, Gelernter J, (2006) Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet 15: 807-819.
50. Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W, (2005) Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 280: 32618-32624.
51. Zhang Z, Pan ZZ, (2010) Synaptic mechanism for functional synergism between delta- and mu-opioid receptors. J Neurosci 30: 4735-4745.